Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B

BAGSVAERD, DENMARK--(Marketwired - May 17, 2013) - Novo Nordisk today announced the completion of paradigmT 2, the first phase 3 trial with a long-acting FIX derivative, N9-GP (glycopegylated recombi…

---

Media Advisory/Photo Opportunity: Calgary’s Blizzard Bayern Celebrate as BMO Team of the Week

- Calgarians invited to attend community celebration at BMO Crowfoot Branch on Tuesday, May 21 - Blizzard eligible to vie for grand prize of $125,000 to refurbish local soccer field in Calgary…

---

Squawk Box Stocks Reports On: Nokia Corporation (NYSE: NOK), Advanced Micro Devices, Inc. (NYSE: AMD), Zynga, Inc. (NASDAQ: ZNGA), Pfizer Inc. (NYSE: PFE)

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit…

---

Novo Nordisk A/S – Share Repurchase Programme

BAGSVAERD, DENMARK--(Marketwired - May 13, 2013) - Company Announcement No 36 2013: http://hugin.info/2013/R/1701189/561614.pdf…

---